Goubert Kristel, Degroote Helena, De Vos Martine, Khalenkow Maxim, Hindryckx Pieter
Ghent University Hospital, Coupure Rechts 136, 9000 Ghent, Belgium.
J Clin Med. 2024 Dec 9;13(23):7481. doi: 10.3390/jcm13237481.
Risk factors for post-endoscopic retrograde cholangiopancreatography (ERCP) complications have been extensively studied and are well established; most complications are mild and self-limiting. This study aims to identify patients at risk of severe early post-ERCP complications. We conducted a retrospective cohort study with data from 2810 ERCP procedures performed at Ghent University Hospital between 2016 and 2022. Patient records and a maintained ERCP registry were used to identify all ERCP-related complications and possible risk factors. The AGREE classification was used to determine the severity of the complication. Univariate and multivariate logistic regression analyses were performed to identify independent predictors of severe complications. Out of 2810 procedures, 223 cases (7.9%) had post-ERCP complications, with severe complications occurring in 20.3% of cases. The most common severe complication was haemorrhage (22/49 severe complications, 44.9%), with perforation having the highest probability of being severe (10/15 cases, 67%). Independent predictors of severe complications included anticoagulative therapy (OR 6.3, 95% CI 1.4-28.3, = 0.016) and high procedural difficulty (Schutz category 3: OR 11.5, 95% CI 2.4-54.6, = 0.002; category 4: OR 5.9, 95% CI 1.4-23.5, = 0.012). Patients on anticoagulation and those undergoing complex ERCP procedures (Schutz 3 or 4) are at particular risk of severe procedure-related complications.
内镜逆行胰胆管造影术(ERCP)后并发症的危险因素已得到广泛研究且已明确;大多数并发症为轻度且具有自限性。本研究旨在识别ERCP术后早期发生严重并发症的风险患者。我们进行了一项回顾性队列研究,使用了2016年至2022年在根特大学医院进行的2810例ERCP手术的数据。通过患者记录和维护的ERCP登记册来识别所有与ERCP相关的并发症及可能的危险因素。采用AGREE分类法确定并发症的严重程度。进行单因素和多因素逻辑回归分析以识别严重并发症的独立预测因素。在2810例手术中,223例(7.9%)发生了ERCP术后并发症,其中20.3%的病例出现严重并发症。最常见的严重并发症是出血(49例严重并发症中有22例,44.9%),穿孔发生严重并发症的概率最高(15例中有10例,67%)。严重并发症的独立预测因素包括抗凝治疗(OR 6.3,95% CI 1.4 - 28.3,P = 0.016)和手术难度高(舒茨分类3:OR 11.5,95% CI 2.4 - 54.6,P = 0.002;分类为4:OR 5.9,95% CI 1.4 - 23.5,P = 0.012)。接受抗凝治疗的患者以及接受复杂ERCP手术(舒茨分类3或4)的患者发生与手术相关严重并发症的风险尤其高。